Article
BRAF and AXL oncogenes drive RIPK3 expression loss in cancer
29 Aug 2018
Abstract excerpt
Necroptosis is a lytic programmed cell death mediated by the RIPK1-RIPK3-MLKL pathway. The loss of Receptor-interacting serine/threonine-protein kinase 3 (RIPK3) expression and necroptotic potential have been previously reported in several cancer cell lines; however, the extent of this loss across cancer types, as well as its mutational drivers, were unknown. Here, we show that RIPK3 expression loss occurs...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
